Nucleus Radiopharma
Kathy Spencer-Pike currently serves as Chief Commercial Officer at Nucleus RadioPharma, focusing on transforming lives through radiopharmaceuticals by integrating clinical, development, and manufacturing expertise. Prior to this role, Kathy held multiple key positions at CoverMyMeds, a McKesson Company, as Chief Sales Officer for Commercialization Services and Operations, managing teams that enhance medication access for patients. Kathy's extensive experience includes serving as Vice President at Novo Nordisk, where responsibilities included overseeing market strategies for diabetes and obesity products, and leading initiatives at Sanofi related to market access and payer strategies for diabetes and cardiovascular portfolios. Kathy began their career at Pfizer, where leadership encompassed managing large teams and substantial revenue accounts. Kathy holds a B.S. in Education from Eastern Kentucky University and an M.A. in Mental Health Counseling from Webster University.
This person is not in any teams
This person is not in any offices
Nucleus Radiopharma
Nucleus RadioPharma is a new company that was founded to ensure that cancer patients have access to potentially life-saving radiopharmaceuticals by developing technologies to modernise the clinical development, manufacturing, and supply chain of these promising new therapies.